4//SEC Filing
Smith Devin Whittemore 4
Accession 0001140361-23-038877
CIK 0001865494other
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 8:38 PM ET
Size
6.6 KB
Accession
0001140361-23-038877
Insider Transaction Report
Form 4
IO Biotech, Inc.IOBT
Smith Devin Whittemore
General Counsel
Transactions
- Award
Warrants (Right to Buy)
2023-08-09$0.13/sh+4,938$617→ 4,938 totalExercise: $2.47From: 2023-08-09→ Common Stock (4,938 underlying) - Award
Common Stock
2023-08-09$1.90/sh+4,938$9,382→ 4,938 total
Footnotes (1)
- [F1]These Warrants expire at 5:00 p.m. Eastern time on the earlier of (i) February 9, 2027, and (ii) one day prior to the closing of an Acquisition of the Issuer, as defined in the Form of Warrant, attached as Exhibit 4.1 to the Issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 7, 2023.
Documents
Issuer
IO Biotech, Inc.
CIK 0001865494
Entity typeother
Related Parties
1- filerCIK 0001747818
Filing Metadata
- Form type
- 4
- Filed
- Aug 8, 8:00 PM ET
- Accepted
- Aug 9, 8:38 PM ET
- Size
- 6.6 KB